Procter & Gamble Health Ltd.
5,603.00-64.0 (-1.13%)
8 Sep, 12:00 AM
Income Statement
Abridged
Understanding Income Statement
Procter & Gamble Health Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
Balance Sheet
Abridged
Understanding Balance Sheet
Procter & Gamble Health Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
Cash Flow
Abridged
Understanding Cash Flow Statement
Procter & Gamble Health Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
Business Segment Analysis
FY End:
Mar 26
Procter & Gamble Health Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.
Capex
Pharmaceuticals (100.0%)₹ 15.51 Cr
Revenue / Sales
Pharmaceuticals (100.0%)₹ 1,407.97 Cr
Assets
Pharmaceuticals (100.0%)₹ 841.35 Cr
Operating Income
Pharmaceuticals (100.0%)₹ 434.94 Cr
Regional Segment Analysis
FY End:
Mar 26
Procter & Gamble Health Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.
Revenue / Sales
India (90.3%)₹ 1,271.45 CrOut of India (9.7%)₹ 136.52 Cr
Historical Segment Analysis
Track how Procter & Gamble Health Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.
Business
Frequently Asked Questions
What is the revenue of Procter & Gamble Health Ltd.?
The latest trailing twelve month revenue of Procter & Gamble Health Ltd. is ₹ 1,432.94 Cr, reflecting a 1-year growth of 12.57% and a 3-year CAGR of 5.23%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Procter & Gamble Health Ltd.?
The latest trailing twelve month net profit (PAT) of Procter & Gamble Health Ltd. is ₹ 356.88 Cr, with a 3-year earnings CAGR of 12.15%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Procter & Gamble Health Ltd.?
The trailing twelve month EBITDA of Procter & Gamble Health Ltd. is approximately ₹ 441.75 Cr (based on an operating margin of 30.83%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Procter & Gamble Health Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Procter & Gamble Health Ltd. is 194.99. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Procter & Gamble Health Ltd.?
The debt-to-equity ratio of Procter & Gamble Health Ltd. stands at 0.02. The interest coverage ratio is 775.00x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Procter & Gamble Health Ltd.?
The estimated book value per share of Procter & Gamble Health Ltd. is 316.01 (derived from a P/B ratio of 17.73 and market price of ₹ 5,603.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Procter & Gamble Health Ltd.?
The trailing twelve month operating cash flow of Procter & Gamble Health Ltd. is ₹ 348.35 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Procter & Gamble Health Ltd. report consolidated or standalone financials?
Procter & Gamble Health Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.